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early-stage dementia at 20-month follow-up. 
 A better perceived quality of relationship with the carer was associated with an increase in 
self-rated quality of life at 20-month follow-up.  
 In this sample, use of acetylcholinesterase-inhibiting medication appeared to be associated 
with a decline in self-rated quality of life at 20-month follow-up.  
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Abstract 
Background: Little evidence is available about how quality of life (QoL) changes as dementia 
progresses.  
Objectives: We explored QoL trajectories over a 20-month period and examined what predicted 
change in QoL. 
Method: Fifty-one individuals with a diagnosis of Alzheimer’s, vascular or mixed dementia (PwD) 
participating in the MIDAS study rated their QoL using the QoL-AD scale at baseline and at 20-
month follow-up. PwD also rated their mood and quality of relationship with the carer. In each case 
the carer rated his/her level of stress and perceived quality of relationship with the PwD.  
Results: There was no change in mean QoL score. Nearly one-third of PwD rated QoL more 
positively at 20-month follow-up and nearly one-third rated QoL more negatively. These changes 
could be regarded as reliable in one-quarter of the sample. Participants taking AChEI medication at 
baseline were more likely to show a decline in QoL score. There were no other significant 
differences between those whose scores increased, decreased or stayed the same on any 
demographic or disease-related variables, or in mood or perceived quality of relationship with the 
carer. While baseline QoL score was the strongest predictor of QoL at 20 months, the quality of 
relationship with the carer as perceived by the PwD was also independently a significant predictor. 
Conclusions: There is a degree of individual variation in QoL trajectories. Use of AChEI 
medication appears linked to decline in QoL score, while positive relationships with carers play an 
important role in maintaining QoL in early-stage dementia. 
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Trajectories of quality of life in early-stage dementia: individual variations and predictors of 
change 
 
It has been argued that, despite considerable research, little is known about the quality of life (QoL) 
of people living with dementia (Banerjee et al., 2009; Hoe et al., 2009; Selwood et al., 2005). This 
may be partly because it has been studied in relation to a relatively limited set of factors (St John 
and Montgomery, 2010). Numerous studies demonstrate that a large proportion of the variance in 
QoL scores, whether self-rated by people with dementia (PwD) or proxy-rated by carers, remains 
unexplained by commonly-measured patient and caregiver factors including symptoms, co-
morbidity, carer burden, and basic demographic variables such as age, gender, education and 
marital status (Naglie et al., 2011a; Naglie et al., 2011b). Depressed mood is a common predictor of 
low QoL scores, but no clear associations emerge with cognitive function, behavioural symptoms or 
functional ability (Banerjee et al., 2009; Naglie et al., 2011a). Even with the inclusion of additional 
factors such as difficulties in the caregiving relationship, studies have only accounted for 38% of 
the variance in QoL scores (Menne et al., 2009).  
If little is known about what predicts QoL in cross-sectional analyses, even less is known 
about how QoL changes as dementia progresses or what factors influence such changes. Follow-up 
studies are few, and typically involve small samples, so the trajectory of QoL and the factors 
associated with change in QoL remain to be clearly established. Studies with care home residents 
have variously reported no change in mean scores at 20 weeks (Hoe et al., 2009) and 1 year 
(Selwood et al., 2005), or significant decline in mean scores at 2 year follow-up (Lyketsos et al., 
2003). Findings from community-dwelling samples with mild to moderate dementia have been 
similarly variable. PwD self-ratings did not change over 2 years (Tatsumi et al., 2009) but proxy 
ratings declined at 16 month (Vogel et al., 2012) or 2 year (Tatsumi et al., 2009) follow-up. In a 
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mixed community and care home sample ranging from mildly to severely impaired, QoL increased 
at 1 year before decreasing at 2 year follow-up (Missotten et al., 2007).  
In addition to group trends, it is important to consider individual variations in QoL 
appraisals and trajectories, and to investigate underlying factors (Vogel et al., 2012). Whether mean 
scores remained the same or declined, all these follow-up studies have noted considerable 
individual variation (Vogel et al., 2012), although little attention has been paid to establishing what 
constitutes a reliable change. In one study of care home residents, over one-third improved and one-
third declined (Hoe et al., 2009), and in another, half the sample improved and half declined 
(Selwood et al., 2005). It has been suggested that increases or reductions in QoL score are not 
directly attributable to changes in clinical variables (Clare et al., 2011; Missotten et al., 2007). The 
effect of depression remains unclear; one study found that lower baseline depression scores 
predicted better self-rated QoL at 20 weeks (Hoe et al., 2009), but another found no effect of 
depression at 2-year follow-up (Lyketsos et al., 2003). Recent findings suggest that social and 
interpersonal factors may play a stronger role; for example, a reciprocal relationship between carer 
stress and perceived quality of relationship and observer-rated PwD well-being six months later has 
been reported (Burgener and Twigg, 2002).  
In this study, we assessed the impact of PwD depression and perceived quality of 
relationship with the carer, and carer stress and perceived quality of relationship with the PwD, at 
baseline on PwD self-ratings of QoL at 20-month follow-up. The following research questions were 
addressed: 
1. What was the profile of QoL trajectories? 
2. Were different QoL trajectories associated with baseline differences in key characteristics (age, 
gender, socio-economic status, and years of education) or illness-related variables (diagnosis, 
functional ability, neuropsychiatric symptoms, and use of acetylcholinesterase-inhibiting 
medication)? 
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3. Did PwD mood and perceived quality of relationship with the carer at baseline, and carer stress 
and perceived quality of relationship with the PwD at baseline, predict PwD QoL scores at 20-
month follow-up? 
 
Methods 
 
Design 
We examined QoL in a community-dwelling sample of people with early-stage Alzheimer’s, 
vascular or mixed dementia participating in the Memory Impairment and Dementia Awareness 
Study (MIDAS). MIDAS was a longitudinal, multi-method study of awareness in people with early-
stage dementia. Participants were assessed on entry (n = 101) and again at approximately 12 (n = 
66) and 20 month (n = 51) time-points. Ethical approval was granted by the relevant University and 
NHS Ethics Committees. As part of a previous, more general analysis, MIDAS data showed no 
change in mean QoL score across all three time-points for the whole sample (Clare et al., 2011). 
This paper presents data from the 51 participants who completed the assessment at both baseline 
and 20-month follow-up, and analyses data from these two time-points only.  
 
Participants 
Participants were recruited from Memory Clinics in North Wales, UK. Inclusion criteria were an 
ICD-10 diagnosis of Alzheimer’s disease (AD), vascular dementia (VaD) or mixed Alzheimer’s and 
vascular dementia (World Health Organisation, 1992), a score of 18 or above on the Mini-Mental 
State Examination (MMSE) (Folstein et al., 1975), ability to communicate verbally in English, and 
availability of a spouse, partner, other family member or friend (‘carer’) who was willing to 
contribute. Exclusion criteria were concurrent major depression, psychosis or other neurological 
disorder, and past history of neurological disorder, stroke or brain injury. Fifty-one participants 
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completed the assessment at both time-points, and in each case a carer also contributed. Sample 
characteristics are summarised in Table 1.  
 
 
(((Table 1 near here))) 
Measures 
The following measures from the MIDAS data set were used in the present analysis. 
 
(a) Measures completed by the PwD 
Quality of life was assessed with the Quality of Life in Alzheimer’s Disease (QoL-AD) scale 
(Logsdon et al., 1999). Mood was assessed with the depression sub-scale of the Hospital Anxiety 
and Depression Scale (HADS) (Snaith and Zigmond, 1994). Perceived quality of relationship with 
the carer was assessed with the Positive Affect Index (Bengtson and Schrader, 1982).  
 
(b) Measures completed by the carer  
Carers rated functional ability of the PwD on the Functional Activities Questionnaire (Pfeffer et al., 
1982), the number and severity of neuropsychiatric symptoms in the PwD on the Neuropsychiatric 
Inventory Questionnaire (Kaufer et al., 2000), and their own levels of stress on the Relative Stress 
Scale (Greene et al., 1982). Perceived quality of relationship with the PwD was assessed with the 
Positive Affect Index (Bengtson and Schrader, 1982). 
 
Procedure 
Participants and carers were visited at home by the researchers, unless they preferred to attend the 
University, and were each seen separately. The baseline MIDAS assessment typically took two or 
three sessions to complete. The assessment at 20 months was  of shorter duration, typically one or 
two sessions. Informed consent was obtained from both PwD and carer at each time-point.  
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Statistical analyses 
Repeated measures ANOVA was used to compare mean QoL scores at baseline and 20-month 
follow-up. Participants were divided into three similar-sized groups consisting of those whose 
scores at 20-month follow-up, relative to baseline, increased by 3 points or more, decreased by 3 
points or more, or stayed the same (± 2 points), in line with Hoe et al. (2009). Scores obtained by 
these groups on baseline variables were compared using ANOVA, chi-square, or the Mantel-
Haenzsel test for linear-by-linear association in IBM SPSS Statistics v.20, as appropriate. A reliable 
change index (Evans et al., 1998) was calculated for the QoL-AD, based on a Cronbach’s alpha of 
.8 for the MIDAS baseline data set. Finally, regression analysis using the stepwise method in IBM 
SPSS Statistics v.20 examined baseline predictors of QoL score at 20-month follow-up for the 
whole sample. The assumptions of equal variability and normality for the residuals were assessed 
and were found to hold. 
 
Results 
 
Mean scores for the 51 participants who provided self-ratings on the QoL-AD at baseline and 20-
month follow-up are summarised in Table 2. There was no difference in mean scores across these 
two time points (F1,50 = .03, p = .87). The stable group mean score masked a degree of individual 
variation, with individual change scores ranging from +15 to -10 points. 
 
(((Table 2 near here))) 
 
Relative to baseline, twenty participants (39%) gave the same rating plus or minus 2 points, 
15 (30%) rated their QoL more positively with scores increasing by 3 points or more, and 16 (31%) 
rated their QoL less positively with scores decreasing by 3 points or more. Mean scores for each of 
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these three groups at each time point are summarised in Table 2. Baseline scores for each of the 
three groups on the other variables of interest are summarised in Table 3. There were no significant 
differences between the groups at baseline in age, gender, socio-economic status, years of 
education, dementia diagnosis,  MMSE score, . depression scores, or perceived quality of 
relationship with the carer. There were also no significant differences between the groups in carer-
rated functional ability or neuropsychiatric symptoms or in carer stress  or perceived quality of 
relationship with the PwD. However, the groups did differ significantly in use of 
acetylcholinesterase-inhibiting (AChEI) medication at baseline; participants treated with AChEI 
medication at baseline were more likely to show a decline in QoL at 20-month follow-up. Baseline 
mean scores for QoL did not differ significantly for those taking and not taking AChEI medication 
(mean on medication 37.52, sd 5.53; mean not on medication 36.42, s.d. 4.66; F1,49 =.59, p = .45). 
Of the 25 participants treated with AChEI medication, 23 had a diagnosis of AD, 1 had a diagnosis 
of mixed AD and vascular dementia, and 1 had a diagnosis of vascular dementia; of the 26 
participants not receiving AChEI medication, 8 had a diagnosis of AD, 8 had a diagnosis of mixed 
AD and vascular dementia, and 10 had a diagnosis of vascular dementia. However, as noted above, 
diagnosis in itself did not result in differences in QoL ratings between the groups. 
 
(((Table 3 near here))) 
 
Calculation of the reliable change index  indicated that a change of 6 points or more in either 
direction was required to be confident that alteration in QoL-AD score was not due to measurement 
unreliability. At 20-month follow-up, 6 participants (12% of the sample) increased their scores by 6 
points or more, and 6 (12% of the sample) decreased their scores by 6 points or more, relative to 
baseline score. Thus, approximately one-quarter of the sample could be considered to have shown 
reliable changes in QoL. 
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Regression analysis examined baseline predictors of QoL score at follow-up for the whole 
sample. QoL score at baseline was entered at the first step and accounted for 35% of variance. At 
the second step, PwD depression score and perceived quality of relationship score were included, 
together with carer stress and perceived quality of relationship scores. All five variables were 
retained in the model, which accounted for 38% of variance, but only baseline QoL score and PwD 
quality of relationship score were individually significant. A further regression analysis including 
just these two variables accounted for 39% of variance, with both QoL and quality of relationship 
individually significant, indicating that higher baseline quality of relationship scores were 
associated with increases in QoL score at follow-up. Thus, while QoL score at baseline was a strong 
predictor of subsequent QoL score at follow-up, the perception held by the PwD of the relationship 
with the carer was also independently predictive, additionally accounting for a small proportion of 
variance.  
 
(((Table 4 near here))) 
 
 
Discussion  
 
This study is one of few to have examined trajectories of self-rated QoL in a community-dwelling 
sample of people with early-stage dementia. While mean QoL score did not change over the 20-
month study period, there was a degree of individual variation, with nearly one-third rating their 
QoL more positively and nearly one-third rating their QoL more negatively at follow-up. Changes 
could be considered reliable for one-quarter of the sample, based on a reliable change index of 6 
points or more in either direction. Comparison of those whose scores increased, declined or stayed 
the same indicated that those taking AChEI medication at baseline were more likely to show a 
decline in QoL score, but yielded no other significant between-group differences in baseline levels 
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of demographic or disease-related variables or in mood, perceived quality of relationship, or carer 
stress. Regression analysis indicated that PwD perceptions of quality of relationship with the carer 
at baseline significantly predicted QoL score at 20-month follow-up; where the relationship was 
evaluated more positively, this was associated with an increase in QoL score. 
The first aim of the study was to examine trajectories of QoL scores over a 20-month period 
in a community-dwelling sample of people with early-stage dementia. We previously reported no 
change in mean QoL score for the whole MIDAS study sample (Clare et al., 2011) over three 
assessment time-points at baseline, 12 and 20 months. The present study demonstrates no change in 
mean score for the sub-group of participants who contributed both at baseline and at 20-month 
follow-up. This is consistent with the finding of no change in mean self-rated QoL scores in the 
most directly comparable study (Tatsumi et al., 2009). Proxy ratings made by carers of community-
dwelling PwD may be more likely to decline (Tatsumi et al., 2009; Vogel et al., 2012). Our finding 
of a degree of individual variation in QoL trajectories was in keeping with findings of previous 
studies (Hoe et al., 2009; Selwood et al., 2005; Vogel et al., 2012). This study was the first to 
consider what constitutes reliable change, demonstrating that one-quarter of the sample showed 
changes in QoL score of a magnitude that was unlikely to result from simple measurement 
unreliability. This highlights the need to take a more individually-focused, person-centred approach 
to understanding the nature and trajectory of QoL in dementia and identifying the factors that 
support improvement in, or maintenance of, QoL, as well as the factors that undermine QoL.  
The second aim of the study was to establish whether different QoL trajectories were 
associated with differences at baseline in key characteristics or illness-related variables. Those 
taking AChEI medication at baseline were more than twice as likely to show a decline in QoL 
scores at 20-month follow-up as those not taking AChEI medication. This pattern could not be 
accounted for by differences in diagnosis or by differences in QoL score at baseline between those 
taking and not taking AChEI medication. It contrasts with previous reports indicating that PwD 
taking AChEI medication rate their QoL more positively than those not taking AChEI medication 
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(Hoe et al., 2007). QoL has been infrequently assessed as an outcome in trials of AChEI medication 
(Birks, 2006). Where effects on self-rated QoL have been evaluated, no benefits of medication have 
been found at 30-week study endpoints (Rogers et al., 1998; Burns et al., 1999); however, evidence 
on longer-term effects on self-rated QoL is lacking. The association between AChEI use and QoL 
trajectory requires further investigation with a larger sample. 
The analyses yielded no evidence of significant differences between the groups at baseline 
on any other variables. Clearly these non-significant findings must be interpreted with some caution 
as group sizes were relatively small and cut-offs for assignment to groups were chosen in line with 
previous research, making it possible to achieve three groups of more or less similar size. However, 
the findings support the view that change in QoL score is not straightforwardly related to most basic 
demographic and disease-related variables (Clare et al., 2011; Missotten et al., 2007), while 
suggesting a potentially important association between prescription of AChEI medication and a 
declining QoL trajectory. 
The third aim of the study was to investigate what predicts change in QoL score over time. 
The strongest predictor of QoL at 20-month follow-up was baseline QoL score. This in part attests 
to the reliability of the scale and the validity of the construct on which it is based. This pattern was 
also expected in the light of previous findings from care home samples (Lyketsos et al., 2003; 
Selwood et al., 2005) follow-up. In line with some previous findings from care home samples 
(Lyketsos et al., 2003), but in contrast to others (Hoe et al., 2009), baseline depression scores did 
not predict QoL at follow-up in our sample. However, uniquely, our study also showed that over 
and above baseline QoL, the perceived quality of relationship with the caregiver significantly 
predicted PwD self-ratings of QoL at follow-up, albeit explaining a modest proportion of the 
variance. This demonstrates the crucial importance of social and relationship factors in supporting 
the QoL of PwD, and highlights the value of focusing on these issues in attempting to understand 
QoL. Social and psychological factors influence individual appraisals of QoL (Byrne-Davis et al., 
2006) and the expectations on which such appraisals are based (Ettema et al., 2005). It is likely that 
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feeling well-supported in a relationship with a trusted carer facilitates more positive appraisals of 
one’s situation and makes it easier to adjust expectations. Carer perceptions of quality of 
relationship, or of the stresses associated with caregiving, were not predictive of PwD QoL. This 
might seem surprising in view of the previous finding that caregiver stress and perceived quality of 
relationship were associated with PwD well-being six months later (Burgener and Twigg, 2002), 
but in that study carer factors were associated with subsequent proxy ratings of PwD well-being, 
rather than with self-ratings by the PwD. Thus, it seems that it is the perceptions held by PwD that 
influence their self-ratings of QoL, while carer perceptions influence proxy ratings of PwD QoL, 
but not PwD self-ratings. This demonstrates the importance of seeking the perspective of the PwD 
wherever possible, rather than relying on proxy ratings.  
As noted above, there are a number of limitations that must be taken into account in 
interpreting the present findings. The QoL-AD scale is a valid and reliable measure which has been 
described as the measure of choice when assessing QoL outcomes for PwD (Moniz-Cook et al., 
2008), but it is important to acknowledge that QoL is a broad concept and that there are differing 
perspectives on how it should be measured (WHOQOL Group, 1994). The sample size of 51 was 
adequate for the regression analyses undertaken to examine predictors of QoL score at 20-month 
follow-up, but the size of the three sub-groups which were identified to permit comparison of scores 
on baseline variables was relatively small. While the group mean scores suggest that the absence of 
significant between-group findings in all variables except for use of AChEI medication was 
generally robust, the small group size may have masked effects in the quality of relationship 
domain. This could be explored further with a larger sample. Additionally, our no-change criterion 
of ± 2 points was consistent with an earlier study (Hoe et al., 2009), but may not have been large 
enough to rule out possible measurement unreliability and regression to the mean; with a larger 
sample it would be possible to make comparisons on the basis of more pronounced changes using 
the reliable change index, here calculated as a 6-point difference, as a cut-off. While the present 
study constituted a first step in considering the impact of psychological and social variables on QoL 
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trajectories, we were only able to consider the predictive value of a relatively limited set of 
variables, selected on the basis of existing evidence. Future studies could draw on a more extensive 
range of variables that might influence change in QoL. Generalisability is limited by the application 
of exclusion criteria covering major depression and past history of psychosis or other neurological 
disorder, and inclusion criteria requiring the involvement of a carer. In this regard it is particularly 
important to note that, unlike participants in the current sample, many PwD do not have a carer or 
other significant person in their lives to offer support and assistance, and these individuals may be 
at particular risk for declining QoL. Finally, the study focused on people with early-stage dementia 
scoring between 18 and 30 on the MMSE at baseline, and hence the findings do not offer 
information about QoL in people with moderate to severe dementia. 
Despite these limitations, the findings contribute new information about factors influencing 
the trajectory of QoL in early-stage dementia, adding to the limited evidence available about change 
over time and providing a detailed focus on potential predictor variables. There is a need for a 
broader perspective if we are to understand variations in QoL among PwD (O’Connor et al., 2007). 
It has been suggested that domains potentially relevant to QoL in dementia include social, 
environmental, economic, cultural and psychological factors (Byrne-Davis et al., 2006; Katsuno, 
2005; Moyle et al., 2011; Murray and Boyd, 2009; Parse, 1996; Smith et al., 2005; Venturato, 
2010). The present findings raise questions about the association between taking AChEI medication 
and QoL, and highlight for the first time the central importance of the perceived quality of 
relationship with a carer as a predictor of subsequent self-ratings of QoL by PwD. Focusing on this 
important domain may offer a vital route to supporting the maintenance or improvement of QoL for 
PwD. 
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Table 1. Sample characteristics 
 
Key characteristic Frequency or mean score (sd; range) 
PwD  
Gender - Female : Male 26 : 25 
Age at baseline 76.75 (7.88; 55 - 91) 
Years of education 11.76 (2.42; 8 - 17) 
Social class based on standard occupational classification 
- I Professional : II Managerial and technical : IIIN 
Skilled non-manual : IIIM Skilled manual : IV Semi-
skilled : V Unskilled 
3 : 14 : 14 : 9 : 8 : 3 
 
Diagnosis - Alzheimer’s : Vascular dementia : Mixed 31 : 11 : 9 
Acetylcholinesterase-inhibiting medication - Yes : No 30 : 21 
MMSE score at baseline 24.5 (2.80; 18 - 30) 
MMSE score at 20-month follow-up 21.61 (5.35; 6 - 30) 
Carer  
Gender - Female : Male  35 : 16 
Age 65.06 (14.50; 33 - 89) 
Relationship to PwD - Spouse : Child : Other relative : 
Friend 
29 : 16 : 4 : 2 
Residing with PwD - Yes : No 32 : 19 
Note: Mini-Mental State Examination (MMSE)  
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Table 2. Mean scores (sds; ranges) for the whole sample and for the three sub-groups at baseline 
and 20-month follow-up 
 
Quality of Life 
rating 
Total sample  
n = 51 
Increased ≥ 3 pts 
n = 15 
Did not change  
n = 20 
Decreased ≥ 3 pts  
n = 16 
Baseline 36.96  
(5.09; 24 - 48) 
35.00  
(4.47; 24 - 43) 
36.70  
(5.55; 27 - 48) 
39.13  
(4.43; 33 - 48) 
20-month  
follow-up 
36.84  
(5.78; 24 - 48) 
40.60  
(3.16; 37 - 46) 
36.60 
(5.68; 25 - 48) 
33.63  
(6.00; 24 - 45) 
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Table 3. Baseline mean scores (sds; ranges) or frequencies for key variables in each QoL group, and statistical comparisons  
 
QoL rating 
 
Increased Did not change  Decreased  Statistical comparison 
PwD N = 15 N = 20 N = 16  
Age 76.00 (10.01; 57-87) 77.40 (6.95; 66-91) 76.06 (7.13; 55-84) F2,48 = .13, p = .88 
Gender F : M 9:6 9:11 9:7 Mantel-Haenszel df 1 = .04, p = .85 
Years of education 12.20 (2.48; 9-17) 11.35 (2.64; 8-17) 11.88 (2.13; 9-17) F2,48 = .54, p = .59 
Social class I : II : IIIN 
: IIIM : IV : V 
1:5:4:2:2:1 2:5:2:4:5:2 0:4:8:3:1:0 Mantel-Haenszel df 1 = .03, p = .87 
Diagnosis  
AD : VaD : Mixed 
8:3:4 12:7:1 11:1:4 Chi-square df 4 = 6.73, p = .15 
AChEI Yes: No 5:10 9:11 11:5 Mantel-Haenszel df 1 = 3.84, p = .05 
MMSE score~ 25.07 (3.53; 18-30) 24.50 (2.54; 19-29) 24.00 (2.39; 20-28) F2,48 = .55, p = .58 
FAQ carer-rated º 12.07 (7.69; 0 – 24) 18.10 (7.81; 3 – 30) 16.88 (6.84; 7 – 28) F2,48 = 2.97, p = .061 
NPI-Q no of 
symptoms° 
4.07 (3.13; 0-9) 4.90 (2.00; 1-9) 4.63 (2.63; 0-8) F2,48 = .46, p = .64 
NPI-Q severity ° 8.00 (7.29; 0-20) 9.30 (4.96; 0-20) 7.88 (5.75; 0-20) F2,48 = .32, p = .73 
Depression° 5.60 (3.50; 0-14) 4.05 (3.25; 0-12) 4.38 (3.69; 0-12) F2,48 = .91, p = .41 
Quality of 
relationship~ 
24.2 (2.73; 20-29) 23.90 (4.74; 10-30) 23.25 (4.04; 16-30) F2,48 = .23, p = .80 
CARER N = 15 N = 20 N = 16  
Stress° 16.79 (11.62; 4-44)* 21.85 (9.23; 8-42) 21.31 (9.87; 6-42) F2,47 = 1.15, p= .32 
Quality of 
relationship~ 
23.87 (5.07; 14-29) 22.35 (3.62; 13-29) 21.56 (3.29; 15-27) F2,48 = 1.32, p = .28 
*n=14 
~ higher score better 
° higher score worse 
Note: Quality of Life (QoL), Alzheimer’s disease (AD), vascular dementia (VaD) or mixed Alzheimer’s and vascular dementia (Mixed), 
acetylcholinesterase-inhibiting medication (AChEI), Mini-Mental State Examination (MMSE), Functional Activities Questionnaire (FAQ), 
Neuropsychiatric Inventory Questionnaire (NPI-Q). 
Mantel-Haenszel here refers to the Mantel-Haenszel test for linear-by-linear association in IBM SPSS Statistics v.20. 
   
21 
 
Table 4. Baseline predictors of QoL score at 20-month follow-up 
 
 Step 1 (baseline QoL 
only) 
Step 2 (all variables) Final analysis with 
significant predictors 
only 
Model Ra
2
 = .35, F1,48 = 27.25, 
p < .001 
Ra
2
 = .38, F5, 44 = 7.03,  
p < .001 
Ra
2
 = .39, F2,48 = 16.67, 
p < .001 
Baseline 
variables 
 
ß                  p 
 
ß                 p ß               p 
PwD QoL  .39               <.001 
 
.39              .02 .45           .001 
PwD depression   
 
-.01             .93   
PwD quality of 
relationship  
 
  
 
.31              .06 .28            .04 
Carer stress   
 
-.20             .15   
Carer quality of 
relationship  
 
  
 
-.13             .89   
 
 
